Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: Evidence from animal and human studies

Journal of Lipid Research

Volumn 44, Issue 12, 2003, Pages 2234-2241

  Larsen, Thomas M ^a   Toubro, Søren ^a   Astrup, Arne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical trial; Fat mass; Fat free mass; Insulin resistance; trans 10, cis 12

Indexed keywords

CONJUGATED LINOLEIC ACID; LINOLEIC ACID; NATROL; NATURES PLUS; NATURES WAY; OLEIC ACID; OLIVE OIL; PLACEBO; SAFFLOWER OIL; SOYBEAN OIL; SUNFLOWER OIL; TONALIN; TROFOCELL; VITAMIN WORLD; YOUR LIFE;

BODY FAT; BREAST MILK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; FAT CONTENT; HUMAN; HYDROGEL; INSULIN RESISTANCE; LIPID STORAGE; LIPODYSTROPHY; LIVER HYPERTROPHY; MILK; NONHUMAN; OBESITY; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; WEIGHT REDUCTION;

ANIMALS; DIETARY SUPPLEMENTS; HUMANS; LINOLEIC ACIDS, CONJUGATED; OBESITY;

EID: 0347093594     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R300011-JLR200     Document Type: Review

References (86)

1. Web Links, D. 2. 2002. (Accessed July 10, 2003 at http://www.npicenter.com/index.asp?action=NBViewDoc&DocumentID=2704)
2. Web Links, D. 2. 2002. (Accessed July 10, 2003 at http://www.cognis.com/framescout.html?/cognis/nutritionandhealth/home.htm).
3. Lawson, R. E., and A. R. Moss. 2002. G.DI. The role of dairy products in supplying conjugated linoleic acid to man's diet: a review. Nutr. Res. Rev. 14: 153-172.
4. Bauman, D. E., and J. M. Griinari. 2000. Regulation and nutritional manipulation of milk fat: low-fat milk syndrome. Livest. Prod. Sci. 70: 15-29.
5. Jiang, J., A. Wolk, and B. Vessby. 1999. Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am. J. Clin. Nutr. 70: 21-27.
6. Ritzenthaler, K. L., M. K. McGuire, R. Falen, T. D. Shultz, N. Dasgupta, and M. A. McGuire. 2001. Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. J. Nutr. 131: 1548-1554.
7. Park, Y., M. K. McGuire, R. Behr, M. A. McGuire, M. A. Evans, and T. D. Shultz. 1999. High-fat dairy product consumption increases delta 9c,11t-18:2 (rumenic acid) and total lipid concentrations of human milk. Lipids. 34: 543-549.
8. Pharma Nord ApS Denmark. 2002. Bio-C.L.A. 80. (Accessed November 27, 2003, at http://www.pharmanord.dk/product.htm?l=dk&id=cla).
9. Roche, H. M., E. Noone, A. Nugent, and M. J. Gibney. 2001. Conjugated linoleic acid: a novel therapeutic nutrient? Nutr. Res. Rev. 14: 173-187.
10. West, D. B., J. P. Delany, P. M. Camet, F. Blohm, A. A. Truett, and J. Scimeca. 1998. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol. 275: R667-R672.
11. Ostrowska, E., D. Suster, M. Muralitharan, R. F. Cross, B. J. Leury, D. E. Bauman, and F. R. Dunshea. 2003. Conjugated linoleic acid decreases fat accretion in pigs: evaluation by dual-energy X-ray absorptiometry. Br. J. Nutr. 89: 219-229.
12. Park, Y., J. M. Storkson, K. J. Albright, W. Liu, and M. W. Pariza. 1999. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 34: 235-241.
13. Gavino, V. C., G. Gavino, M. J. Leblanc, and B. Tuchweber. 2000. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J. Nutr. 130: 27-29.
14. Ryder, J. W., C. P. Portocarrero, X. M. Song, L. Cui, M. Yu, T. Combatsiaris, D. Galuska, D. E. Bauman, D. M. Barbano, M. J. Charron, J. R. Zierath, and K. L. Houseknecht. 2001. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes. 50: 1149-1157.
15. Belury, M. A., S. Y. Moya-Camarena, K. L. Liu, and J. P. Vanden Heuvel. 1997. Dietary conjugated linoleic acid induces peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J. Nutr. Biochem. 8: 579-584.
16. DeLany, J. P., F. Blohm, A. A. Truett, J. A. Scimeca, and D. B. West. 1999. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am. J. Physiol. 276: R1172-R1179.
17. Belury, M. A., and A. Kempa-Steczko. 1997. Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids. 32: 199-204.
18. Cherian, G., T. B. Holsonbake, M. P. Goeger, and R. Bildfell. 2002. Dietary CLA alters yolk and tissue FA composition and hepatic histopathology of laying hens. Lipids. 37: 751-757.
19. de Deckere, E. A., J. M. van Amelsvoort, G. P. McNeill, and P. Jones. 1999. Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster. Br. J. Nutr. 82: 309-317.
20. Yamasaki, M., K. Mansho, H. Mishima, G. Kimura, M. Sasaki, M. Kasai, H. Tachibana, and K. Yamada. 2000. Effect of dietary conjugated linoleic acid on lipid peroxidation and histological change in rat liver tissues. J. Agric. Food Chem. 48: 6367-6371.
21. Jones, P. A., L. J. Lea, and R. U. Pendlington. 1999. Investigation of the potential of conjugated linoleic acid (Cla) to cause peroxisome proliferation in rats. Food Chem. Toxicol. 37: 1119-1125.
22. Moya-Camarena, S. Y., J. P. Van den Heuvel, and M. A. Belury. 1999. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim. Biophys. Acta. 1436: 331-342.
23. Kritchevsky, D., S. A. Tepper, S. Wright, P. Tso, and S. K. Czarnecki. 2000. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J. Am. Coll. Nutr. 19 (Suppl.): 472-477.
24. Munday, J. S., K. G. Thompson, and K. A. James. 1999. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br. J. Nutr. 81: 251-255.
25. Houseknecht, K. L., J. P. Vanden Heuvel, S. Y. Moya-Camarena, C. P. Portocarrero, L. W. Peck, K. P. Nickel, and M. A. Belury. 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 244: 678-682. [Erratum. 1998. Biochem. Biophys. Res. Commun. 247: 911.].
26. Houseknecht, K. L., J. P. Vanden Heuvel, S. Y. Moya-Camarena, C. P. Portocarrero, L. W. Peck, K. P. Nickel, and M. A. Belury. 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 244: 678-682. [Erratum. 1998. Biochem. Biophys. Res. Commun. 247: 911.].
27. Henriksen, E. J., M. K. Teachey, Z. C. Taylor, S. Jacob, A. Ptock, K. Kramer, and O. Hasselwander. 2003. Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am. J. Physiol. Endocrinol. Metab. 285: E98-E105.
28. McCarthy-Beckett, D. O. 2002. Dietary supplementation with conjugated linoleic acid does not improve nutritional status of tumor-bearing rats. Res. Nurs. Health. 25: 49-57.
29. Bouthegourd, J. C., P. C. Even, D. Gripois, B. Tiffon, M. F. Blouquit, S. Roseau, C. Lutton, D. Tome, and J. C. Martin. 2002. A CLA mixture prevents body triglyceride accumulation without affecting energy expenditure in Syrian hamsters. J. Nutr. 132: 2682-2689.
30. Roche, H. M., E. Noone, C. Sewte, S. McBennett, D. Savage, M. J. Gibney, S. O'Rahilly, and A. J. Vidal-Puig. 2002. Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes. 51: 2037-2044.
31. Tsuboyama-Kasaoka, N., M. Takahashi, K. Tanemura, H. J. Kim, T. Tange, H. Okuyama, M. Kasai, S. Ikemoto, and O. Ezaki. 2000. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes. 49: 1534-1542.
32. Tsuboyama-Kasaoka, N., H. Miyazaki, S. Kasaoka, and O. Ezaki. 2003. Increasing the amount of fat in a conjugated linoleic acid-supplemented diet reduces lipodystrophy in mice. J. Nutr. 133: 1793-1799.
33. Clement, L., H. Poirier, I. Niot, V. Bocher, M. Guerre-Millo, S. Krief, B. Staels, and P. Besnard. 2002. Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J. Lipid Res. 43: 1400-1409.
34. Degrace, P., L. Demizieux, J. Gresti, J. M. Chardigny, J. L. Sebedio, and P. Clouet. 2003. Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10,cis-12-linoleic acid. FEBS Lett. 546: 335-339.
35. Takahashi, Y., M. Kushiro, K. Shinohara, and T. Ide. 2003. Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. Biochim. Biophys. Acta. 1631: 265-273.
36. Smith, S. B., T. S. Hively, G. M. Cortese, J. J. Han, K. Y. Chung, P. Castenada, C. D. Gilbert, V. L. Adams, and H. J. Mersmann. 2002. Conjugated linoleic acid depresses the delta9 desaturase index and stearoyl coenzyme A desaturase enzyme activity in porcine subcutaneous adipose tissue. J. Anim. Sci. 80: 2110-2115.
37. Lee, K. N., M. W. Pariza, and J. M. Ntambi. 1998. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression. Biochem. Biophys. Res. Commun. 248: 817-821.
38. Choi, Y., Y. C. Kim, Y. B. Han, Y. Park, M. W. Pariza, and J. M. Ntambi. 2000. The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J. Nutr. 130: 1920-1924.
39. Baumgard, L. H., B. A. Corl, D. A. Dwyer, A. Saebo, and D. E. Bauman. 2000. Identification of the conjugated linoleic acid isomer that inhibits milk fat synthesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278: R179-R184.
40. Baumgard, L. H., E. Matitashvili, B. A. Corl, D. A. Dwyer, and D. E. Bauman. 2002. Trans-10, cis-12 conjugated linoleic acid decreases lipogenic rates and expression of genes involved in milk lipid synthesis in dairy cows. J. Dairy Sci. 85: 2155-2163.
41. Piperova, L. S., B. B. Teter, I. Bruckental, J. Sampugna, S. E. Mills, M. P. Yurawecz, J. Fritsche, K. Ku, and R. A. Erdman. 2000. Mammary lipogenic enzyme activity, trans fatty acids and conjugated linoleic acids are altered in lactating dairy cows fed a milk fat-depressing diet. J. Nutr. 130: 2568-2574.
42. Peterson, D. G., L. H. Baumgard, and D. E. Bauman. 2002. Short communication: milk fat response to low doses of tran-10, cis-12 conjugated linoleic acid (CLA). J. Dairy Sci. 85: 1764-1766.
43. Baumgard, L. H., J. K. Sangster, and D. E. Bauman. 2001. Milk fat synthesis in dairy cows is progressively reduced by increasing supplemental amounts of trans-10, cis-12 conjugated linoleic acid (CLA). J. Nutr. 131: 1764-1769.
44. Bee, G. 2000. Dietary conjugated linoleic acid consumption during pregnancy and lactation influences growth and tissue composition in weaned pigs. J. Nutr. 130: 2981-2989.
45. Masters, N., M. A. McGuire, K. A. Beerman, N. Dasgupta, and M. K. McGuire. 2002. Maternal supplementation with CLA decreases milk fat in humans. Lipids. 37: 133-138.
46. Thompson, H., Z. Zhu, S. Banni, K. Darcy, T. Loftus, and C. Ip. 1997. Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. Cancer Res. 57: 5067-5072.
47. Raes, K., G. Huyghebaert, S. De Smet, L. Nollet, S. Arnouts, and D. Demeyer. 2002. The deposition of conjugated linoleic acids in eggs of laying hens fed diets varying in fat level and fatty acid profile. J. Nutr. 132: 182-189.
48. Aydin, R., M. W. Pariza, and M. E. Cook. 2001. Olive oil prevents the adverse effects of dietary conjugated linoleic acid on chick hatchability and egg quality. J. Nutr. 131: 800-806.
49. Ntambi, J. M., M. Miyazaki, J. P. Stoehr, H. Lan, C. M. Kendziorski, B. S. Yandell, Y. Song, P. Cohen, J. M. Friedman, and A. D. Attie. 2002. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA. 99: 11482-11486.
50. West, D. B., F. Y. Blohm, A. A. Truett, and J. P. DeLany. 2000. Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J. Nutr. 130: 2471-2477.
51. Hargrave, K. M., C. Li, B. J. Meyer, S. D. Kachman, D. L. Hartzell, M. A. Della-Fera, J. L. Miner, and C. A. Baile. 2002. Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic acid in mice. Obes. Res. 10: 1284-1290.
52. Brown, J. M., Y. D. Halvorsen, Y. R. Lea-Currie, C. Geigerman, and M. McIntosh. 2001. Trans-10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J. Nutr. 131: 2316-2321.
53. Brown, J. M., M. S. Boysen, S. S. Jensen, R. F. Morrison, J. Storkson, R. Lea-Currie, M. Pariza, S. Mandrup, and M. K. McIntosh. 2003. Isomer-specific regulation of metabolism and PPAR{gamma} signaling by CLA in human preadipocytes. J. Lipid Res. 44: 1287-1300.
54. Kang, K., W. Liu, K. J. Albright, Y. Park, and M. W. Pariza. 2003. Trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPAR gamma expression. Biochem. Biophys. Res. Commun. 303: 795-799.
55. Granlund, L., L. K. Juvet, J. I. Pedersen, and H. I. Nebb. 2003. Trans10, cis12 conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J. Lipid Res. 44: 1441-1452
56. Azain, M. J., D. B. Hausman, M. B. Sisk, W. P. Flatt, and D. E. Jewell. 2000. Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J. Nutr. 130: 1548-1554.
57. Bouthegourd, J. C., J. C. Martin, D. Gripois, S. Roseau, M. F. Blouquit, P. C. Even, and A. Quignard Boulange. 2002. Efficacy of dietary CLA and CLA plus Guarana (ADI Pill) on body adiposity, and adipocytes cell number and size (part 1, March 20, 2002). FASEB J. 16: A370.
58. Xu, X., and M. W. Pariza. 2002. Dietary conjugated linoleic acid reduces mouse adipocyte size and number (part 1, March 20, 2002). FASEB J. 16: A370.
59. Atkinson, R. L. 2002. Effects of CLA in Obese Subjects on a Weight Loss Diet: Wisconsin Data (Abstract). NIH seminar. Perspectives on Conjugated Linoleic Acid Research: Current Status and Future Directions. Bethesda, MD.
60. Kamphuis, M. M., M. P. Lejeune, W. H. Saris, and M. S. Westerterp-Plantenga. 2003. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int. J. Obes. Relat. Metab. Disord. 27: 840-847.
61. Riserus, U., P. Arner, K. Brismar, and B. Vessby. 2002. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 25: 1516-1521.
62. Riserus, U., S. Basu, S. Jovinge, G. N. Fredrikson, J. Arnlov, and B. Vessby. 2002. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 106: 1925-1929.
63. Basu, S., A. Smedman, and B. Vessby. 2000. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett. 468: 33-36.
64. Atkinson, R. L. 1999. Chapter 27. Conjugated linoleic acid for altering body composition and treating obesity. In Advances in Conjugated Linoleic Acid Research. M. P. Yurawecz, M. M. Mossoba, J. K. G. Kramer, M. W. Pariza, and G. J. Nelson, editors. American Oil Chemists' Society Press, Champaign, IL. 348-353.
65. Berven, G., A. Bye, O. Hals, H. Blankson, H. Fagertun, E. Thom, J. Wadstein, and O. Gudmundsen. 2000. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur. J. Lipid Sci. Technol. 102: 455-462.
66. Ascherio, A., M. B. Katan, P. L. Zock, M. J. Stampfer, and W. C. Willett. 1999. Trans fatty acids and coronary heart disease. N. Engl. J. Med. 340: 1994-1998.
67. Lemaitre, R. N., I. B. King, T. E. Raghunathan, R. M. Pearce, S. Weinmann, R. H. Knopp, M. K. Copass, L. A. Cobb, and D. S. Siscovick. 2002. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation. 105: 697-701.
68. Belury, M. A., and J. P. Vanden Heuvel. 1999. Chapter 32. Modulation of diabetes by conjugated linoleic acid. In Advances in Conjugated Linoleic Acid Research. M. P. Yurawecz, M. M. Mossoba, J. K. G. Kramer, M. W. Pariza, and G. J. Nelson, editors. American Oil Chemists' Society Press, Champaign, IL. 405-410.
69. Pariza, M. W. 2002. Conjugated linoleic acid may be useful in treating diabetes by controlling body fat and weight gain. Diabetes Technol. Ther. 4: 335-338.
70. Oakes, N. D., P. G. Thalen, S. M. Jacinto, and B. Ljung. 2001. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes. 50: 1158-1165.
71. Larsen, T. M., S. Toubro, and A. Astrup. 2003. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int. J. Obes. Relat. Metab. Disord. 27: 147-161.
72. Franckhauser, S., S. Munoz, A. Pujol, A. Casellas, E. Riu, P. Otaegui, B. Su, and F. Bosch. 2002. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes. 51: 624-630.
73. Kim, J. K., J. J. Fillmore, Y. Chen, C. Yu, I. K. Moore, M. Pypaert, E. P. Lutz, Y. Kako, W. Velez-Carrasco, I. J. Goldberg, J. L. Breslow, and G. I. Shulman. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA. 98: 7522-7527.
74. Adlof, R. O., L. C. Copes, and E. L. Walter. 2001. Changes in conjugated linoleic acid composition within samples obtained from a single source. Lipids. 36: 315-317.
75. Gaullier, J. M., G. Berven, H. Blankson, and O. Gudmundsen. 2002. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids. 37: 1019-1025.
76. Zambell, K. L., N. L. Keim, M. D. Van Loan, B. Gale, P. Benito, D. S. Kelley, and G. J. Nelson. 2000. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids. 35: 777-782.
77. Benito, P., G. J. Nelson, D. S. Kelley, G. Bartolini, P. C. Schmidt, and V. Simon. 2001. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids. 36: 229-236. [Erratum. 2001. Lipids. 36: 857.]
78. Benito, P., G. J. Nelson, D. S. Kelley, G. Bartolini, P. C. Schmidt, and V. Simon. 2001. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids. 36: 229-236. [Erratum. 2001. Lipids. 36: 857.]
79. Thom, E., J. Wadstein, and O. Gudmundsen. 2001. Conjugated linoleic acid reduces body fat in healthy exercising humans. J. Int. Med. Res. 29: 392-396.
80. Smedman, A., and B. Vessby. 2001. Conjugated linoleic acid supplementation in humans-metabolic effects. Lipids. 36: 773-781.
81. Mougios, V., A. Matsakas, A. Petridou, S. Ring, A. Sagredos, A. Melissopoulou, N. Tsigilis, and M. Nikolaidis. 2001. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J. Nutr. Biochem. 12: 585-594.
82. Blankson, H., J. A. Stakkestad, H. Fagertun, E. Thom, J. Wadstein, and O. Gudmundsen. 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J. Nutr. 130: 2943-2948.
83. Riserus, U., L. Berglund, and B. Vessby. 2001. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int. J. Obes. Relat. Metab. Disord. 25: 1129-1135.
84. Kreider, R. B., M. P. Ferreira, M. Greenwood, M. Wilson, and A. L. Almada. 2002. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J. Strength Cond. Res. 16: 325-334.
85. Noone, E. J., H. M. Roche, A. P. Nugent, and M. J. Gibney. 2002. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br. J. Nutr. 88: 243-251.
86. Belury, M. A., A. Mahon, and S. Banni. 2003. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J. Nutr. 133: 257S-260S.